Natural History and Disease Progression Biomarkers of Multiple System Atrophy

NACompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

May 26, 2020

Primary Completion Date

May 30, 2022

Study Completion Date

October 28, 2022

Conditions
Multiple System Atrophy
Interventions
DIAGNOSTIC_TEST

MRI acquisition

MRI acquisition

DIAGNOSTIC_TEST

DAT-SPECT

Imaging with DAT SPECT (Dopamine Transporter, Single Photon Emission Computed Tomography)

DIAGNOSTIC_TEST

blood sample, cerebrospinal fluid (optional)

blood sample, cerebrospinal fluid

BEHAVIORAL

Evaluations about motor abilities, depression, cognition and lifestyle

Evaluations about motor abilities (UMSAR scale), depression (BDI scale), cognition (MoCA scale) and lifestyle (MSA- QoL)

BEHAVIORAL

Evaluation about depression cognition

Evaluations about depression (BDI scale), cognition (MoCA scale)

Trial Locations (10)

13000

Hôpital de La Timone, Marseille

31000

CHU, Toulouse

33076

CHU de Bordeaux, Bordeaux

44093

Clinique neurologique - Hôpital Laennec, Nantes

54035

CHU de Nancy, Nancy

59037

CHU Lille, Lille

63003

Chu Clermont Ferrand, Clermont-Ferrand

67098

Hôpital de Hautepierre, Strasbourg

69677

Hôpital Neurologique Pierre Wertheimer, Bron

75013

Hôpital Pitié-Salpêtrière, Paris

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT04229173 - Natural History and Disease Progression Biomarkers of Multiple System Atrophy | Biotech Hunter | Biotech Hunter